David L. Grange, Chief Executive Officer at PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI), sold 51,753 shares at $25.71 ($1.3M) on 2010-11-03, disclosed to the SEC on 2010-11-04.
Open-market sale of $1.3M PPDI by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.00 | 373 | $10K | 0.7% |
| 2 | $25.71 | 51,380 | $1.3M | 99.3% |
| Total | $25.71 avg | 51,753 | $1.3M | 100% |
| Filing → |
| PPDI | SELL | 2007-07-27 | $184K | — | Filing → |
| PPDI | SELL | 2007-02-12 | $205K | — | Filing → |
| PPDI | SELL | 2006-05-24 | $362K | — | Filing → |